Explore

Program Map

Start with a treatment, device, company, diagnosis, or trial ID. Each record keeps the source trail close to the claim.

161Main(26 active)

148Status checked

135Strong

320Backlog

More filters and sort (2 active)

Company-led only

1 records in Main database · 1 strong · 1 status checked

Compare	Program	Company	Type	Product	Modality	Stage	Status	Reliability	Evidence	Conf.	Population	Indications	Inspect
Add	ACOU085 by Acousia Therapeutics	Acousia Therapeutics GmbH	Therapeutic	-	Small Molecule	Phase 2	Active	Details checkedStrong evidence	company · Priority 2	93%	AdultAge-Related+1	Hearing LossSensorineural Hearing Loss+2

Acousia Therapeutics GmbH · Small Molecule · Phase 2

ActiveTherapeuticStronger sources

Evidence

company

Confidence

93%

Indications

Hearing LossSensorineural Hearing LossAge-Related Hearing LossCisplatin-Induced Hearing Loss

Population

AdultAge-RelatedCisplatin Ototoxicity